Scientists Have Developed A Vaccine For Depression That Could Prevent Soldiers Getting PTSD
Our society has taken commendable steps towards understanding more sensitive to the situation already misunderstood, to a large extent, a case, in the days of days, I had encountered anomalies of deception and a sense of “union” would send those who suffer Of the deepest depression in cycle, you can feel like there is no escape.
Although many argue that the funding of mental health research is still largely weak compared to the impact of mental illness in our society – just because the disease is invisible, it does not mean that it is not tangible, it is not real.
Developments have led our understanding of depression and related illnesses to the most complex and effective treatment methods ever, as well as accepting society exponentially from those who suffer from this situation – improvement can not be pull apart.
It is gratifying also to consider new ways to treat depression that are being sought and sought, where medical researchers to gain a deeper understanding of the science behind seeking mental illnesses. Rebecca Pracman is one of these benevolent individual, she believes she has achieved something of a breakthrough.
Pracman is a neuroscientist at the age of 34 at Columbia University, and is believed to have succeeded in developing a new treatment that builds a kind of mental toughness that allows people to be exposed to terrible events without the need To relieve this annoying form after the fact.
Again in 2014, as part of a larger study of the emotional behavior of mice, Prachman administered ketamine – a drug that has long been considered a potential treatment for depression and other related disorders. Using mice in this significant study, it is already known that the effects of ketamine in mice will disappear after only a few hours.
After several weeks, Pracman returned to the mice, to conduct a study of ways to cope with stressful events. He dramatically found that the mice given the drug in the weeks before appeared to be contradictory symptoms and usually referred to cases that had developed.
After the experiment several times, Pracman concluded that ketamine appears to improve the ability to withstand and overcome typical triggers that may adversely affect, in normal circumstances, the mental health of mice.
What makes the results, especially in particular, is the idea that this medication can be used as prophylaxis against post-traumatic stress disorder and depression, not a cure rather than symptoms may already appear in the individual.
If the results are encouraging, similarly in clinical trials in humans, the Pracman anticipates potential drug benefit under conditions such as soldiers who had rushed before entering potentially horrific war zones, or distress personnel before traveling To disaster areas.
If we succeed, the future of mental health care can become prevention rather than treatment. He is currently working on the development of Pracman’s special drug edition, and plans to carry out trials on humans next year.
Here is the hope that they will continue to break new ground on the road to a brighter future for those suffering from mental health.